Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Results of pre-registration studies of the vaccine against Strangles of horses

View through CrossRef
Horse breeding in Yakutia is associated with year-round grazing and tebenevok keeping of horses. In herd horse breeding, the most common infectious disease is Strangles horses. In the republic, the incidence of Strangles from the total number of young horses is 57.8-62.7%, mortality - 4.0-22.0%. An effective method of combating this infection is vaccination. Based on this, we have developed a new inactivated vaccine against Strangles horses with an immunomodulator, made from the bacterial strain Str. equi "H-5/1", as an immunomodulator added centrate strain of bacteria Bac. subtilis TNP-3. Preclinical trials on laboratory animals (white mice, rabbits) showed that the vaccine protects up to 90% of white mice from experimental infection with a pathogenic strain of mytaceous streptococcus. According to the results of clinical observation, pathoanatomical autopsy, histological examination, it was established that the vaccine does not negatively affect the general condition of animals, does not have allergenic properties, does not cause pathological changes in organs and tissues, and does not have a toxic effect on the body of laboratory animals. Clinical trials were carried out on foals 6-8 months of age. The efficiency of immunization was 97.6%. With the introduction of the development in a separate farm, the economic effect per head will be 3.99 thousand rubles, per 1 ruble of costs - 6.65 rubles. In general, the republic will receive an economic effect in the amount of 49 million 356 thousand rubles. Thus, the method of specific prevention of Strangles horses developed by us is environmentally safe, highly immunogenic and cost-effective. Scientific and technical documentation and the vaccine against myta successfully passed the examination of the VGNKI of veterinary drugs. The vaccine is registered in the register of medicinal products for veterinary use (Rosselkhoznadzor of the Russian Federation) under registration number No. 71-1-27.21-4828 No. PVR-1-27.21/03691 dated 08.12.2021.
Title: Results of pre-registration studies of the vaccine against Strangles of horses
Description:
Horse breeding in Yakutia is associated with year-round grazing and tebenevok keeping of horses.
In herd horse breeding, the most common infectious disease is Strangles horses.
In the republic, the incidence of Strangles from the total number of young horses is 57.
8-62.
7%, mortality - 4.
0-22.
0%.
An effective method of combating this infection is vaccination.
Based on this, we have developed a new inactivated vaccine against Strangles horses with an immunomodulator, made from the bacterial strain Str.
equi "H-5/1", as an immunomodulator added centrate strain of bacteria Bac.
subtilis TNP-3.
Preclinical trials on laboratory animals (white mice, rabbits) showed that the vaccine protects up to 90% of white mice from experimental infection with a pathogenic strain of mytaceous streptococcus.
According to the results of clinical observation, pathoanatomical autopsy, histological examination, it was established that the vaccine does not negatively affect the general condition of animals, does not have allergenic properties, does not cause pathological changes in organs and tissues, and does not have a toxic effect on the body of laboratory animals.
Clinical trials were carried out on foals 6-8 months of age.
The efficiency of immunization was 97.
6%.
With the introduction of the development in a separate farm, the economic effect per head will be 3.
99 thousand rubles, per 1 ruble of costs - 6.
65 rubles.
In general, the republic will receive an economic effect in the amount of 49 million 356 thousand rubles.
Thus, the method of specific prevention of Strangles horses developed by us is environmentally safe, highly immunogenic and cost-effective.
Scientific and technical documentation and the vaccine against myta successfully passed the examination of the VGNKI of veterinary drugs.
The vaccine is registered in the register of medicinal products for veterinary use (Rosselkhoznadzor of the Russian Federation) under registration number No.
71-1-27.
21-4828 No.
PVR-1-27.
21/03691 dated 08.
12.
2021.

Related Results

Burden of the Beast
Burden of the Beast
Introduction Throughout the COVID-19 pandemic, and its fluctuating waves of infections and the emergence of new variants, Indigenous populations in Australia and worldwide have re...
Determination of the tolerability of the combined vaccine against Rhinopneumonia and Strangles on young horses
Determination of the tolerability of the combined vaccine against Rhinopneumonia and Strangles on young horses
Infectious diseases are registered annually in herd horse breeding. One of the most common diseases among young horses are rhinopneumonia and strangles. According to the Department...
Combined Trivalent Vaccine for Young Horses
Combined Trivalent Vaccine for Young Horses
The horse strangles, rhinopneumonia, and salmonella abortion are most often recordedin the regions engaged in breeding herd horses. Young horses are most affected by these infectio...
Volatility Trade Design
Volatility Trade Design
Using data from the Eurodollar options on futures market, this paper examines six volatility trades: straddles, strangles, guts, butterflies, iron butterflies, and condors. We arg...
Results of clinical trials of a trivalent vaccine for horses
Results of clinical trials of a trivalent vaccine for horses
We have developed a trivalent vaccine made from the SV/69 strain of the Rhinopneumonia virus (RHIV), the bacteria strains of Salmonella abortus equi BN-12 - the causative agent of ...
Nasopharyngeal Microbiomes in Donkeys Shedding Streptococcus equi Subspecies equi in Comparison to Healthy Donkeys
Nasopharyngeal Microbiomes in Donkeys Shedding Streptococcus equi Subspecies equi in Comparison to Healthy Donkeys
Streptococcus equi subsp. equi (S. equi) is the pathogen causing strangles, a highly infectious disease that can affect equids including donkeys of all ages. It can persistently co...
Rotavirus gastroenteritis hospitalisations following introduction of vaccination, Canberra
Rotavirus gastroenteritis hospitalisations following introduction of vaccination, Canberra
Objectives: To determine the effect of rotavirus vaccination on rotavirus hospitalisations in children under 5 years of age at The Canberra Hospital, Australian Capital Territory.M...

Back to Top